FeesSafety
Pluang+

China's central bank buys gold for 23 months amid economic worries and dollar diversification.

Market News
12 Oct 2026, 03:51 WIB
CNBC
View Source
Bullish
China's central bank buys gold for 23 months amid economic worries and dollar diversification.

China's central bank has purchased gold for 23 consecutive months, reflecting Beijing's strategy to reduce reliance on the U.S. dollar and diversify reserves. Chinese households and companies are also increasing gold buying as a safe haven amid a weak property market and stock performance. Despite falling gold prices, demand remains strong, supporting bullion prices against rising U.S. yields. Analysts expect continued demand and price growth into early 2027, driven by geopolitical concerns and limited domestic investment alternatives.

The story about China's record gold imports is presented here with Pluang's market data for context. For readers following US stocks, here is Pluang's market snapshot as of Oct 12, 2026 08:02 WIB: out of 150 priced US stocks tradable on Pluang, 112 rose and 38 fell. Among notable movers, Affirm Holdings Inc (AFRM) rose by 7.56% to USD 81.00 with a typical hold time of 21 days, while Intel Corp (INTC) declined by 6.90% to USD 105.31 with a typical hold time of 116 days, and Li Auto Inc (LI) increased by 6.55% to USD 11.71 with a typical hold time of 102 days.

More News

Theriva Biologics announces 1-for-30 reverse stock split effective Dec 2, 2026 to meet NYSE price requirements

Theriva Biologics announces 1-for-30 reverse stock split effective Dec 2, 2026 to meet NYSE price requirements

Theriva Biologics, a clinical-stage biotech company, announced a 1-for-30 reverse stock split effective December 2, 2026. This move reduces the number of outstanding shares from about 45.9 million to approximately 1.53 million to meet the New York St...

Company Fundamentals
Neutral
1 hour ago
Nebius shares drop 40% despite strong growth; $7B ARR target delayed to Feb 2027, long-term outlook remains positive.

Nebius shares drop 40% despite strong growth; $7B ARR target delayed to Feb 2027, long-term outlook remains positive.

Nebius' stock fell over 40% in a month due to a two-month delay in reaching its $7 billion annual recurring revenue (ARR) target, now expected by February 2027. This delay was caused by third-party provider issues, but the company is improving its da...

Market News
Bullish
1 hour ago
FitLife Brands cuts costs and locks in raw material prices to protect margins amid stable revenue.

FitLife Brands cuts costs and locks in raw material prices to protect margins amid stable revenue.

FitLife Brands reported a 9% revenue increase to $25.6 million in Q3 2026 while managing cost pressures through strategic forward purchases of whey protein and fish oil, expanding working capital by $3.5 million to hedge against commodity inflation. ...

Company Fundamentals
Bullish
1 hour ago
Weibo's Q3 revenue falls 7% amid cautious ad spending; AI tools boost ad campaign setup efficiency.

Weibo's Q3 revenue falls 7% amid cautious ad spending; AI tools boost ad campaign setup efficiency.

Weibo reported a 7% year-over-year decline in total third-quarter 2026 revenues to $410.2 million, with advertising revenue down 8% to $344.1 million due to reduced ad budgets in key consumer sectors. Despite this, targeted content marketing, especia...

Company Fundamentals
Neutral
1 hour ago
Nvidia seen as top AI stock to buy during market downturn due to strong fundamentals and growth potential.

Nvidia seen as top AI stock to buy during market downturn due to strong fundamentals and growth potential.

Nvidia is highlighted as a strong AI stock choice during a market crash because of its robust financial health, critical role in AI technology, and significant growth potential. Despite recent challenges like CEO changes and regulatory concerns, Nvid...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App